These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22889672)

  • 1. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease.
    Sánchez-López F; Tasset I; Agüera E; Feijóo M; Fernández-Bolaños R; Sánchez FM; Ruiz MC; Cruz AH; Gascón F; Túnez I
    Neurol Res; 2012 Sep; 34(7):721-4. PubMed ID: 22889672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NGF and nitrosative stress in patients with Huntington's disease.
    Tasset I; Sánchez-López F; Agüera E; Fernández-Bolaños R; Sánchez FM; Cruz-Guerrero A; Gascón-Luna F; Túnez I
    J Neurol Sci; 2012 Apr; 315(1-2):133-6. PubMed ID: 22251933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral biomarkers of oxidative stress and their limited potential in evaluation of clinical features of Huntington's patients.
    Ciancarelli I; De Amicis D; Di Massimo C; Di Scanno C; Pistarini C; D'Orazio N; Tozzi Ciancarelli MG
    Biomarkers; 2014 Sep; 19(6):452-6. PubMed ID: 24980251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
    Stoy N; Mackay GM; Forrest CM; Christofides J; Egerton M; Stone TW; Darlington LG
    J Neurochem; 2005 May; 93(3):611-23. PubMed ID: 15836620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important role of oxidative stress biomarkers in Huntington's disease.
    Túnez I; Sánchez-López F; Agüera E; Fernández-Bolaños R; Sánchez FM; Tasset-Cuevas I
    J Med Chem; 2011 Aug; 54(15):5602-6. PubMed ID: 21678912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects : a cross-sectional study.
    Klepac N; Relja M; Klepac R; Hećimović S; Babić T; Trkulja V
    J Neurol; 2007 Dec; 254(12):1676-83. PubMed ID: 17990062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study.
    Tang Q; Liu H; Shi XJ; Cheng Y
    Oxid Med Cell Longev; 2020; 2020():9187195. PubMed ID: 32963705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
    Chen CM; Wu YR; Cheng ML; Liu JL; Lee YM; Lee PW; Soong BW; Chiu DT
    Biochem Biophys Res Commun; 2007 Jul; 359(2):335-40. PubMed ID: 17543886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of Interleukin-6 in Saliva, but Not Plasma, Correlate with Clinical Metrics in Huntington's Disease Patients and Healthy Control Subjects.
    Corey-Bloom J; Fischer RS; Kim A; Snell C; Parkin GM; Granger DA; Granger SW; Thomas EA
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of inflammatory markers in Huntington's Disease plasma.
    Silajdžić E; Rezeli M; Végvári Á; Lahiri N; Andre R; Magnusson-Lind A; Nambron R; Kalliolia E; Marko-Varga G; Warner TT; Laurell T; Tabrizi SJ; Björkqvist M
    J Huntingtons Dis; 2013; 2(1):125-34. PubMed ID: 25063434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of thioredoxin, oxidative stress markers, inflammation and muscle/renal damage following intensive endurance exercise.
    Sugama K; Suzuki K; Yoshitani K; Shiraishi K; Miura S; Yoshioka H; Mori Y; Kometani T
    Exerc Immunol Rev; 2015; 21():130-42. PubMed ID: 25826051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidative stress in alterations of hematological parameters and inflammatory markers induced by early hypercholesterolemia.
    Karbiner MS; Sierra L; Minahk C; Fonio MC; Bruno MP; Jerez S
    Life Sci; 2013 Oct; 93(15):503-8. PubMed ID: 23994665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress.
    Haring R; Baumeister SE; Völzke H; Dörr M; Kocher T; Nauck M; Wallaschofski H
    J Androl; 2012; 33(5):944-50. PubMed ID: 22207707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic inflammatory changes and increased oxidative stress in rural Indian women cooking with biomass fuels.
    Dutta A; Ray MR; Banerjee A
    Toxicol Appl Pharmacol; 2012 Jun; 261(3):255-62. PubMed ID: 22521606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do glial cells play an anti-oxidative role in Huntington's disease?
    Gao Y; Chu SF; Li JP; Zuo W; Wen ZL; He WB; Yan JQ; Chen NH
    Free Radic Res; 2014 Oct; 48(10):1135-44. PubMed ID: 24957138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
    Christofides J; Bridel M; Egerton M; Mackay GM; Forrest CM; Stoy N; Darlington LG; Stone TW
    J Neurochem; 2006 May; 97(4):1078-88. PubMed ID: 16573644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Ryu JK; Choi HB; McLarnon JG
    Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and plasma aminopeptidase activity in Huntington's disease.
    Duran R; Barrero FJ; Morales B; Luna JD; Ramirez M; Vives F
    J Neural Transm (Vienna); 2010 Mar; 117(3):325-32. PubMed ID: 20094738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.